Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000200743 | SCV000251060 | benign | not specified | 2014-07-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics Inc | RCV000710073 | SCV000612261 | benign | not provided | 2017-09-21 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000200743 | SCV000707362 | benign | not specified | 2017-04-17 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000710073 | SCV001108996 | benign | not provided | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000710073 | SCV001371558 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | COQ8A: BP4, BP7, BS2 |
Prevention |
RCV003907729 | SCV004725612 | benign | COQ8A-related condition | 2019-06-27 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |